期刊文献+

复合前列腺特异性抗原测定在前列腺疾病诊断中的应用 被引量:2

在线阅读 下载PDF
导出
摘要 目的研究复合前列腺特异性抗原(CPSA)测定在前列腺疾病诊断中的意义。方法选取血清总PSA(TPSA)4.0~10.0μg/L且经病理组织活检诊断为前列腺癌(PCa 32例)及前列腺增生(BPH 46例)患者血清标本,采用化学发光法检测TPSA、游离PSA(fPSA)、CPSA,并计算fPSA/TPSA,并以55例正常体检者为对照。结果BPH组和PCa组TPSA相比无显著性差异(t=1.137,P>0.05),CPSA相比有显著性差异(t=9.652,P<0.01),fPSA/TPSA相比有显著性差异(t=2.461,P<0.05)。BPH组和PCa组TPSA、CPSA与对照组比较,均有显著性差异。结论在PCa和BPH鉴别诊断中,CPSA检测明显是更好的实验室指标。
出处 《现代中西医结合杂志》 CAS 2007年第23期3372-3373,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献5

二级参考文献53

  • 1牛颖,章学林,方邦江,朱培庭,张静哲.锦红汤对急性胆源性感染全身性炎症反应综合征的调节作用[J].中国中西医结合杂志,2004,24(8):707-709. 被引量:18
  • 2章学林,张静喆,顾宏刚,马恩伟,朱培庭.大鼠梗阻性胆管炎细胞免疫功能降低及中药锦红片的影响[J].世界华人消化杂志,2007,15(18):2050-2053. 被引量:14
  • 3Louha M;Roussin k;Ganne n.Spontanceus and intiogenic spreading of liver-derived cells into peripheral blood of patients liver cancer[J],1997(04).
  • 4Papsidero LD;Wang MC;Valanzuela LA.A Prostate specific antigen in sera of prostate cancer patient,1980(10).
  • 5Zhang WM;Finne p;Leinonen J.Measurement of the complex between prostate-specific antigen and alpha 1-protease inhibitor in surm,1999.
  • 6Zhang WM;Finnel P;Leinonen J.Determinatation of prostate-specific antigen complexed with a2-macroglobulin in serm increase the specificity of free to total PSA for prostate cancer[J],2000(2).
  • 7Brandle E;Hautmann O;Bachem M.serum half life time determination of free and total prostate-specific antigen following radical prostatectomy-a critical assessment[J],1999(4).
  • 8Lilja H;Haese A;Bjork T.Significance and metabolism of complexed and noncomplexed prostate-specific antigen forms and human glandular kallikrein-2 in clinically localized prostate cancer before and after radical prostatectomy[J],1999.
  • 9Horninger W;Ressigil A;Rogatsch H.Prostate cancer screening in the Tyrol Austra,experience and results[J],2000.
  • 10Hudson MA.Clinical use of prostate-specific antigen in patients with prostatic cancer,1989.

共引文献46

同被引文献27

  • 1王从容,裘宇容,曾方银,魏东,孙朝晖.结合型PSA及其与总PSA的比值在前列腺癌诊断中的应用评价[J].临床检验杂志,2005,23(5):365-366. 被引量:2
  • 2高远,臧运江,卢洪凯.医源性因素对血清前列腺特异性抗原的影响[J].潍坊医学院学报,2005,27(6):414-417. 被引量:5
  • 3吕元 朱汉民 沈霞.临床实验诊断学[M].上海:上海科学技术出版社,2004.23-31.
  • 4Armstrong A J, Tannock IF, De Wit R, et al. The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival[ J]. Eur J Cancer,2010,46(3) :517-525.
  • 5Bunting PS. Screening for prostate cancer with prostate-specific antigen:beware the biases[ J]. C lin Chim Acta, 2002,315 (1-2 ): 71-97.
  • 6Wang MC, Valenzuela LA, Murphy GP, et al. Purification of a human prostate specific antigen [ J ]. Invest Urol, 1979, 17 (2) : 159-163.
  • 7Papsidero LD, Wang MC, Valenzuela LA, et al. A prostate antigen in sera of prostatic cancer patients [ J ]. Cancer Res, 1980,40 (7) : 2428-2432.
  • 8Nogueira L, Corradi R, Eastham JA. Prostatic specific antigen for prostate cancer detection [ J ]. Int Braz J Urol, 2009,35 ( 5 ) : 521-529.
  • 9Leinonen J, Zhang WM, Stenman UH. Complex formation between PSA isoenzymes and protease inhibitors [ J ]. J Urol, 1996,155 (3) :1099-1103.
  • 10Stenman UH, Leinonen J, Alfthan H, et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer : assay of the complex improves clinical sensitivity for cancer [J]. Cancer Res,1991,51 ( 1 ) :222-226.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部